Stock Region Penny Picks
Stock Region Penny Picks Watchlist: Top Market Movers & Insights
Stock Region Penny Picks Watchlist: Top Market Movers & Insights
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The information provided in this newsletter is for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or an endorsement of any stock. Always do your own research and consult with a licensed financial advisor before making any investment decisions. Trading carries significant risk.
The market has been absolutely wild lately, and if you’ve been paying attention to the news wire, you know that opportunity is hiding in plain sight. We’ve sifted through the noise to bring you the most compelling catalysts, earnings beats, and strategic pivots from the past few days.
Let’s dive right into the watchlist and talk about what these moves actually mean for you.
🚀 The Earnings Crushers
$FIEE (FiEE, Inc.)
The News: Q4 and Full-Year 2025 results showed an insane 867.9% year-over-year revenue growth and a net income turnaround.
Our Take: You simply cannot ignore near-900% growth. Achieving profitability while scaling at that speed is incredibly rare. This is a massive turnaround story, and if they maintain even a fraction of this momentum, $FIEE needs to be glued to your radar.
$GOAI (EVA Live Inc.)
The News: Revenues surged 82.6% to $17 million, swinging the company to an $8.1 million net income.
Our Take: An $8.1 million profit on $17 million in revenue means their margins are absolutely beautiful right now. We love seeing a company convert top-line growth into bottom-line cash so efficiently.
$TNON (Tenon Medical)
The News: Record FY 2025 revenue of $3.9 million (up 20%), with a huge Q4 spike of $1.5 million (up 92%).
Our Take: The massive Q4 jump shows they are catching fire late in the year. Strong second-half momentum usually bleeds into the next quarter. Keep an eye on their Q1 2026 guidance.
🛡️ Defense & Tech Pivots
$MOBX (Mobix Labs)
The News: Entering the smart munitions market through an anti-drone feasibility program.
Our Take: Defense tech is heating up, and anti-drone technology is exactly where government budgets are shifting. This is a smart, timely pivot for $MOBX.
$CHNR (CHNR)
The News: Signed an LOI to acquire a majority stake in HooRii Technology, shifting toward “Physical AI.”
Our Take: AI is the buzzword of the decade, but bridging the gap to physical AI (hardware/robotics) is where the next trillion-dollar market lies. If this acquisition closes, it completely changes CHNR’s valuation model.
$SPCB (SuperCom)
The News: Won a $17 million national electronic monitoring contract in Sweden.
Our Take: Government contracts offer reliable, recurring revenue. A $17 million anchor contract provides excellent financial stability and proves their tech can win on a global stage.
💰 Big Money Moves & Buybacks
$WGRX (Wellgistics Health Inc.)
The News: Signed a staggering $105 million LOI to evaluate acquiring Neuritek Therapeutics.
Our Take: A $105 million LOI is no joke. Neuritek is working on innovative neurological therapies. If $WGRX pulls this off, they instantly become a major player in a highly lucrative biotech sector.
$TRNR (TRNR)
The News: Authorized a $500,000 stock repurchase program, representing 20% of outstanding shares.
Our Take: We love buybacks. When a company buys up 20% of its float, management is screaming to the market: “We think our stock is severely undervalued.” It tightens the supply and usually rewards shareholders.
🌍 Global Expansion & Commodities
$CODX (Co-Diagnostics)
The News: Expanding commercial and distribution territory across South Asia.
Our Take: South Asia is a massive, densely populated market. If Co-Diagnostics can secure strong distribution channels there, the revenue upside is tremendous.
$BRN (Barnwell Industries)
The News: Highlighting revenue leverage to rising oil prices while undergoing a strategic review.
Our Take: Rising oil prices are a tailwind here, but the “strategic review” is the real kicker. That phrase often hints at a potential sale, merger, or spin-off. Watch this one closely for sudden updates.
$SMX (SMX)
The News: Pushing material efficiency as oil and gas volatility drives up everyday goods costs.
Our Take: They are positioning themselves as a solution to inflation and supply chain woes. It’s a great narrative, provided they can execute.
📉 To Keep on The Radar
$NOTE (FiscalNote): Partnering to monetize political prediction content. With the political climate heating up, this is an incredibly smart way to generate new revenue streams.
$UGRO (urban-gro): Expanding their T20 cricket footprint via a merger. It’s an unusual play, but T20 cricket has a rabid global fanbase.
$BNGO (Bionano): Reported Q4 results and gave 2026 outlook. Dig into their specific guidance numbers to see if they can justify current valuations.
Disclaimer: The commentary provided in this newsletter reflects the personal opinions of the authors and does not represent absolute market truths. Stocks mentioned may be highly volatile and illiquid. We are not responsible for any financial losses you may incur. Do your due diligence, manage your risk appropriately, and never invest money you cannot afford to lose.